These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38686386)

  • 1. Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity.
    Bu S; Royston L; Mabanga T; Berini CA; Tremblay C; Lebouché B; Cox J; Costiniuk CT; Durand M; Isnard S; Routy JP
    Front Immunol; 2024; 15():1377126. PubMed ID: 38686386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
    Ebihara T; Matsumoto H; Matsubara T; Togami Y; Nakao S; Matsuura H; Kojima T; Sugihara F; Okuzaki D; Hirata H; Yamamura H; Ogura H
    Front Immunol; 2021; 12():798338. PubMed ID: 35095877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
    Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
    Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammatory marker GDF-15 is not independently associated with late-life depression.
    Teunissen CE; Durieux-Lu S; Blankenstein MA; Oude Voshaar RC; Comijs HC
    J Psychosom Res; 2016 Apr; 83():46-9. PubMed ID: 27020076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults.
    Kou H; Jin X; Gao D; Ma R; Dong X; Wei J; Wang X
    Clin Exp Hypertens; 2018; 40(1):8-15. PubMed ID: 29035099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
    Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
    Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
    Front Immunol; 2021; 12():678661. PubMed ID: 34335580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19.
    Ishak SR; Ganzoury MME; Fouda EM; Anwar MA; Kamal AM; Hamza HM; Bakry NA
    Eur J Med Res; 2023 Nov; 28(1):527. PubMed ID: 37974205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Biobanque québécoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories.
    Tremblay K; Rousseau S; Zawati MH; Auld D; Chassé M; Coderre D; Falcone EL; Gauthier N; Grandvaux N; Gros-Louis F; Jabet C; Joly Y; Kaufmann DE; Laprise C; Larochelle C; Maltais F; Mes-Masson AM; Montpetit A; Piché A; Richards JB; Tse SM; Turgeon AF; Turecki G; Vinh DC; Wang HT; Mooser V;
    PLoS One; 2021; 16(5):e0245031. PubMed ID: 34010280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.
    Montoro-García S; Hernández-Romero D; Jover E; García-Honrubia A; Vilchez JA; Casas T; Martínez P; Climent V; Caballero L; Valdés M; Marín F
    Eur J Intern Med; 2012 Mar; 23(2):169-74. PubMed ID: 22284249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.
    Vila G; Riedl M; Anderwald C; Resl M; Handisurya A; Clodi M; Prager G; Ludvik B; Krebs M; Luger A
    Clin Chem; 2011 Feb; 57(2):309-16. PubMed ID: 21164037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study.
    Mourouzis K; Siasos G; Bozini N; Oikonomou E; Zaromitidou M; Tsigkou V; Kokkou E; Bletsa E; Stampouloglou P; Vavuranakis M; Tousoulis D
    Recent Adv Inflamm Allergy Drug Discov; 2022; 16(2):107-115. PubMed ID: 36336806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
    Kim JS; Kim S; Won CW; Jeong KH
    Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDF-15 in solid vs non-solid treatment-naïve malignancies.
    Arfsten H; Cho A; Freitag C; Raderer M; Goliasch G; Bartko PE; Wurm R; Strunk G; Gisslinger H; Marosi C; Kornek G; Zielinski C; Hülsmann M; Pavo N
    Eur J Clin Invest; 2019 Nov; 49(11):e13168. PubMed ID: 31463975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome.
    Tektonidou MG; Papassotiriou I; Sfikakis PP
    Rheumatology (Oxford); 2021 Dec; 61(1):394-399. PubMed ID: 33748838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19.
    Brasen CL; Christensen H; Olsen DA; Kahns S; Andersen RF; Madsen JB; Lassen A; Kierkegaard H; Jensen A; Sydenham TV; Madsen JS; Møller JK; Brandslund I
    Clin Chem Lab Med; 2021 Nov; 59(12):1988-1997. PubMed ID: 34455731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
    Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.